InvestorsHub Logo
Followers 21
Posts 980
Boards Moderated 0
Alias Born 03/20/2019

Re: HinduKush post# 324675

Wednesday, 02/10/2021 9:13:06 PM

Wednesday, February 10, 2021 9:13:06 PM

Post# of 426250
As I mentioned before, if there has to be a rehearing, well I like our chances with this panel consisting of Newman & Moore.

Look at what one of the panel judges commented during the hearing at the CAFC. I don't know if Newman or Moore said this:

During an appeals hearing Wednesday in GSK’s suit against Teva, a federal judge on the U.S. Federal Circuit Court's panel in Washington, D.C., said she was “bewildered” by U.S. District Judge Leonard P. Stark’s decision to strike the jury's original verdict.

The Circuit Court judge, who was not identified in a recording of the proceedings, said she couldn’t “imagine a stronger case for induced infringement” of a drug’s patent. Press releases Teva issued before and after its generic Coreg approval presented its copycat as an “equivalent” to the branded drug despite GSK's patent protection, she pointed out.

https://www.fiercepharma.com/pharma/i-m-quite-frankly-baffled-teva-s-235m-patent-infringement-overturn-leaves-judge-bewildered
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News